A brief description is provided of the Malaria Consortium’s COMDIS-supported work on the evaluation of out‐patient malaria case management under the new Artemether‐Lumefantrine (AL) policy for uncomplicated malaria in 4 areas of different malaria transmission intensities in Uganda. It was found that: there was often a lack of concurrent availability of all age‐specific doses of AL, and a lack of training and information; the use of AL nevertheless prevailed (60%) over the use of non-effective or non-recommended therapies; many patients still however received non-recommended therapy or no malaria therapy at all; the specificity and positive predictive value (PPV) of policy recommendations were very low (cases of non-malarial fever were often not identified as such); and use of routine malaria microscopy was low and interpretation and accuracy of results were poor. The potential benefits and impact of the research are discussed.
Anon. Report on Malaria Consortium&#8217;s COMDIS supported work on an evaluation of outpatientmalaria case management practices in Uganda. (2009) 4 pp.